Fernando Molina
Family Medicine · Rome, GANPI 1396807186
Payments from drug & device makers
What this record shows
Almost everything reported here is food and beverage — 99.5% of the total across 232 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. It is spread thinly across 29 manufacturers, the largest accounting for just 12.1% — the pattern of someone who eats at a lot of different presentations. Reporting peaked in 2019 at $1,659 and has fallen 95.5% since, to $75 in 2023.
Across 232 payments — averaging $14.56 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Boehringer Ingelheim$410
- Pfizer$384
- Amgen$308
- AbbVie$278
- Astellas Pharma US Inc$268
- AstraZeneca$223
- plus $2K from 23 others
What the payments were for
- Food & beverage$3,36199%
- Education$181%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Boehringer Ingelheim | 27 | $410 |
| Pfizer | 34 | $384 |
| Amgen(2 entities) | 20 | $308 |
| AbbVie(2 entities) | 21 | $278 |
| Astellas Pharma US Inc | 15 | $268 |
| AstraZeneca | 13 | $223 |
| Amarin Pharma, Inc. | 15 | $217 |
| GSK | 15 | $194 |
| Johnson & Johnson | 12 | $185 |
| Merck | 14 | $180 |
| Sanofi-aventis U.S. LLC | 10 | $157 |
| Takeda Pharmaceuticals U.S.A., Inc. | 7 | $124 |
| Novartis | 5 | $77 |
| Lilly USA, LLC | 5 | $65 |
| Novo Nordisk | 3 | $42 |
| Salix Pharmaceuticals, A Division Of Bausch Health US, LLC | 2 | $36 |
| Abbott | 2 | $32 |
| Dynavax Technologies Corporation | 1 | $23 |
| Daiichi Sankyo Inc. | 1 | $21 |
| Ultragenyx Pharmaceutical Inc. | 1 | $20 |
| Esperion Therapeutics, Inc. | 1 | $19 |
| Shire North American Group Inc | 1 | $17 |
| Biohaven Pharmaceuticals, Inc. | 1 | $16 |
| Mylan Specialty L.p. | 1 | $16 |
| Varian Medical Systems, Inc. | 1 | $16 |
| Sanofi Pasteur Inc. | 1 | $15 |
| Currax Pharmaceuticals LLC | 1 | $14 |
| Teva Pharmaceuticals USA, Inc. | 1 | $13 |
| Kowa Pharmaceuticals America, Inc. | 1 | $12 |
How this compares
$3,379 in reported general payments places this provider in the 80th percentile of 3,111 family medicine providers in Georgia.
Other family medicine in Rome
- Christina DouglassRome$33K
- Jeffrey KingsleyColumbus$404K
- Debbie HaginsSavannah$279K
- Yolanda WadeTyrone$233K
- Julian HutchinsWarrenton$222K
- Nadine Halliburton-FosterCumming$219K
- Contessa MetcalfeAtlanta$157K
- Elmore AlexanderStone Mountain$155K
- Bantwal BaligaColumbus$115K
- Avril CampbellFort Benning$108K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.